April 17, 2012
Karl Y. Hostetler, MD, has been selected as the recipient of the 2012 Gertrude Elion Memorial Lecture Award by the International Society of Antiviral Research. Hostetler is a professor of medicine in the Divisions of Infectious Diseases and Endocrinology at the UC San Diego School of Medicine.
April 19, 2021
Researchers discover that brain cancer tumors reprogram immune cells to help them grow, rather than suppress them.
March 11, 2024
UC San Diego Health provides the most advanced neurological cancer care by combining leading-edge surgical techniques and the latest technology.
July 10, 2024
The grant from The Leukemia & Lymphoma Society will fund research on the affordability and utilization of fertility preservation with health insurance for adolescent young adults with blood cancers.
December 19, 2013
UC San Diego Sulpizio Cardiovascular Center (SCVC) has been featured in the latest Becker’s Hospital Review list of “100 Hospitals with Great Heart Programs.” Hospitals were selected based on quality care, clinical accolades and research contributions to the field of cardiovascular care.
June 21, 2024
UC San Diego School of Medicine international study shows new drug improves sleep, health in patients diagnosed with obesity and sleep apnea.
August 29, 2023
A $5 million gift from the Nancy and Geoffrey Stack Foundation has established the UC San Diego Gene Therapy Initiative to find novel therapies for children and adults with genetic diseases.
June 1, 2018
…California San Diego School of Medicine have found that treatment with cirmtuzumab, an experimental monoclonal antibody-based drug, measurably inhibited the “stemness” of chronic lymphocytic leukemia cancer (CLL) cells — their ability to self-renew and resist terminal differentiation and senescence.
January 30, 2014
In studying the impact of DNA damage on the Golgi, a research team from the University of California, San Diego School of Medicine and the Ludwig Institute for Cancer Research have discovered a novel pathway activated by DNA damage, with important consequences for the body’s cellular response to chemotherapy.
February 7, 2018
Treating obese mice with catestatin (CST), a peptide naturally occurring in the body, showed significant improvement in glucose and insulin tolerance and reduced body weight, report University of California San Diego School of Medicine researchers.
